351 related articles for article (PubMed ID: 27900619)
1. Current Perspectives on Antihypertensive Probiotics.
Daliri EB; Lee BH; Oh DH
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):91-101. PubMed ID: 27900619
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive activity of blueberries fermented by Lactobacillus plantarum DSM 15313 and effects on the gut microbiota in healthy rats.
Ahrén IL; Xu J; Önning G; Olsson C; Ahrné S; Molin G
Clin Nutr; 2015 Aug; 34(4):719-26. PubMed ID: 25194632
[TBL] [Abstract][Full Text] [Related]
3. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
4. Zhengganxifeng Decoction Affects Gut Microbiota and Reduces Blood Pressure via Renin-Angiotensin System.
Yu X; Zhang X; Jin H; Wu Z; Yan C; Liu Z; Xu X; Liu S; Zhu F
Biol Pharm Bull; 2019; 42(9):1482-1490. PubMed ID: 31474709
[TBL] [Abstract][Full Text] [Related]
5. Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk.
Usinger L; Ibsen H; Linneberg A; Azizi M; Flambard B; Jensen LT
Clin Physiol Funct Imaging; 2010 Mar; 30(2):162-8. PubMed ID: 20113315
[TBL] [Abstract][Full Text] [Related]
6. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
[TBL] [Abstract][Full Text] [Related]
7. Invited review: Effect of antihypertensive fermented milks on gut microbiota.
Beltrán-Barrientos LM; García HS; Hernández-Mendoza A; González-Córdova AF; Vallejo-Cordoba B
J Dairy Sci; 2021 Apr; 104(4):3779-3788. PubMed ID: 33752288
[TBL] [Abstract][Full Text] [Related]
8. [Blockers of renin-angiotensin-aldosterone system in the treatment of arterial hypertension: classics versus the modern].
Kanorskiĭ SG
Kardiologiia; 2013; 53(10):89-95. PubMed ID: 24645559
[TBL] [Abstract][Full Text] [Related]
9. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
Schmieder RE
Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
[TBL] [Abstract][Full Text] [Related]
10. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
12. Influence of dietary modifications on the blood pressure response to antihypertensive medication.
Huggins CE; Margerison C; Worsley A; Nowson CA
Br J Nutr; 2011 Jan; 105(2):248-55. PubMed ID: 20807467
[TBL] [Abstract][Full Text] [Related]
13. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
Qi Y; Kim S; Richards EM; Raizada MK; Pepine CJ
Circ Res; 2017 May; 120(11):1724-1726. PubMed ID: 28546357
[TBL] [Abstract][Full Text] [Related]
15. Hypertension as a Metabolic Disorder and the Novel Role of the Gut.
Tanaka M; Itoh H
Curr Hypertens Rep; 2019 Jun; 21(8):63. PubMed ID: 31236708
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia.
Borghi C; Urso R; Cicero AF
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):115-120. PubMed ID: 27745933
[TBL] [Abstract][Full Text] [Related]
17. Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
Furberg CD; Sealey JE; Blumenfeld JD
Am J Hypertens; 2017 Sep; 30(9):857-860. PubMed ID: 28482060
[TBL] [Abstract][Full Text] [Related]
18. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
19. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
Verdecchia P; Gentile G; Angeli F; Reboldi G
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
[TBL] [Abstract][Full Text] [Related]
20. Peptides as targets for antihypertensive drug development.
Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
